2BB score and signals
Unicycive Therapeutics, Inc.’s current 2BB score is 20 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 3 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 40 | Normal |
| Risk | 54 | Moderate |
Company facts
| Founded | 2016 |
| Employees | 22 |
| 52-week range | $3.72 – $8.74 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.3206 | — | $0.00 |
| 2026-08-17 | — | -0.343 | — | $0.00 |
| 2026-05-12 | -0.54 | -0.5168 | $0.00 | $0.00 |
| 2026-03-30 | -0.819 | -0.4828 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish